Investors

Novozymes and Chr. Hansen propose to combine

March 30, 2023, announcement

Novozymes’ and Chr. Hansen’s shareholders approve the combination to create a leading global biosolutions partner. For legal reasons, the announcement and all related material to the announcement can only be found on this dedicated site.

In accordance with section 245 of the Danish Companies Act, copies of the statutory Merger Plan, Merger Statement, Auditor Statements and Annual Reports for the past three financial years for Novozymes and Chr. Hansen are available for review at Chr. Hansen’s offices, located at Boege Alle 10-12, DK-2970 Hoersholm, Denmark, upon request in the reception. The documents are also available via the above link.